Old Web
English
Sign In
Acemap
>
authorDetail
>
Janet W. Baird
Janet W. Baird
Glasgow Royal Infirmary
Dasatinib
Molecular biology
Biology
Stem cell
Imatinib
4
Papers
600
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
imatinib in primary CML, but does not eliminate the quiescent fraction Dasatinib (BMS-354825) targets an earlier progenitor population than
2013
Joanne C. Mountford
Tessa L. Holyoake
Mhairi Copland
Ashley Hamilton
Lucy J. Elrick
Janet W. Baird
Elaine K. Allan
Show All
Source
Cite
Save
Citations (0)
Combined BCR-ABL inhibition with lentiviral-delivered shRNA and dasatinib augments induction of apoptosis in Philadelphia-positive cells.
2009
Experimental Hematology
Svetlana Myssina
G. Vignir Helgason
Alan Serrels
Heather G. Jørgensen
Ravi Bhatia
Hardik Modi
Janet W. Baird
Joanne C. Mountford
Ashley Hamilton
Mirle Schemionek
Steffen Koschmieder
Valerie G. Brunton
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (3)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
2006
Blood
Mhairi Copland
Ashley Hamilton
Lucy J. Elrick
Janet W. Baird
Elaine K. Allan
Niove E. Jordanides
Martin Barow
Joanne C. Mountford
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (594)
Dasatinib (BMS-354825) Has Increased Activity Against Bcr-Abl Compared to Imatinib in Primary CML Cells In Vitro , but Does Not Eradicate Quiescent CML Stem Cells.
2005
Blood
Mhairi Copland
Ashley Hamilton
Janet W. Baird
Martin Barow
Elaine K. Allan
Lucy J. Elrick
Tessa L. Holyoake
Show All
Source
Cite
Save
Citations (3)
1